Brokerages Set Omega Protein Corp. (NYSE:OME) PT at $25.65
Omega Protein Corp. (NYSE:OME) has been assigned a consensus rating of “Buy” from the six analysts that are currently covering the firm. Four analysts have rated the stock with a hold recommendation, one has issued a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $25.65.
A number of research analysts recently commented on the company. Zacks Investment Research cut Omega Protein Corp. from a “buy” rating to a “hold” rating in a report on Thursday, July 7th. Pivotal Research boosted their price target on Omega Protein Corp. from $25.00 to $30.00 and gave the stock a “buy” rating in a report on Tuesday, August 2nd. Wunderlich cut Omega Protein Corp. from a “buy” rating to a “hold” rating and boosted their price target for the stock from $22.00 to $26.00 in a report on Friday, August 5th. Finally, DA Davidson lifted their price objective on Omega Protein Corp. from $20.00 to $26.00 and gave the stock a “neutral” rating in a research note on Thursday, August 4th.
Shares of Omega Protein Corp. (NYSE:OME) opened at 23.36 on Tuesday. Omega Protein Corp. has a 52 week low of $14.58 and a 52 week high of $26.00. The stock has a market cap of $521.04 million, a price-to-earnings ratio of 19.16 and a beta of 0.87. The company has a 50-day moving average price of $24.70 and a 200-day moving average price of $20.74.
Omega Protein Corp. (NYSE:OME) last posted its quarterly earnings results on Wednesday, August 3rd. The company reported $0.62 EPS for the quarter, topping the Zacks’ consensus estimate of $0.48 by $0.14. Omega Protein Corp. had a return on equity of 14.70% and a net margin of 7.03%. The company had revenue of $112.65 million for the quarter, compared to analysts’ expectations of $99.12 million. During the same period in the previous year, the firm earned $0.43 EPS. The firm’s revenue was up 20.9% compared to the same quarter last year. Equities analysts anticipate that Omega Protein Corp. will post $2.03 EPS for the current year.
In other news, Director Gary L. Allee sold 11,200 shares of the business’s stock in a transaction that occurred on Thursday, September 22nd. The stock was sold at an average price of $24.34, for a total transaction of $272,608.00. Following the transaction, the director now owns 46,101 shares of the company’s stock, valued at approximately $1,122,098.34. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Mark Edward Griffin sold 75,000 shares of the business’s stock in a transaction that occurred on Monday, September 12th. The shares were sold at an average price of $25.12, for a total value of $1,884,000.00. Following the transaction, the insider now directly owns 149,891 shares in the company, valued at approximately $3,765,261.92. The disclosure for this sale can be found here. 7.40% of the stock is owned by company insiders.
Several institutional investors have recently added to or reduced their stakes in OME. Wedge Capital Management L L P NC increased its position in Omega Protein Corp. by 29.7% in the second quarter. Wedge Capital Management L L P NC now owns 45,800 shares of the company’s stock valued at $916,000 after buying an additional 10,500 shares in the last quarter. Hillsdale Investment Management Inc. increased its position in Omega Protein Corp. by 12.4% in the second quarter. Hillsdale Investment Management Inc. now owns 18,100 shares of the company’s stock valued at $362,000 after buying an additional 2,000 shares in the last quarter. Highbridge Capital Management LLC bought a new position in Omega Protein Corp. during the second quarter valued at $441,000. AQR Capital Management LLC increased its position in Omega Protein Corp. by 24.5% in the second quarter. AQR Capital Management LLC now owns 621,397 shares of the company’s stock valued at $12,421,000 after buying an additional 122,377 shares in the last quarter. Finally, A.R.T. Advisors LLC increased its position in Omega Protein Corp. by 157.5% in the second quarter. A.R.T. Advisors LLC now owns 29,425 shares of the company’s stock valued at $588,000 after buying an additional 18,000 shares in the last quarter. 86.85% of the stock is currently owned by hedge funds and other institutional investors.
Omega Protein Corp. Company Profile
Omega Protein Corporation is a nutritional products company that develops, produces and delivers nutritious products across the world. The Company operates through two segments: animal nutrition and human nutrition. The Company’s animal nutrition segment consists primarily of two subsidiaries: Omega Protein, Inc (Omega Protein) and Omega Shipyard, Inc (Omega Shipyard).
Receive News & Stock Ratings for Omega Protein Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Protein Corp. and related stocks with our FREE daily email newsletter.